Uromodulin: A Novel Regulator of the Kidney–Adipose Axis in Diabetic Kidney Disease
International Journal of Molecular Sciences · 04.07.2026 · 27 (13) · 6009
DOI: 10.3390/ijms27136009 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2026. Verfasst von Linan Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing 100034, China. Hauptthemen laut MEDLINE: Uromodulin, Diabetic Nephropathies, Kidney, Diabetes Mellitus, Experimental. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National High-Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
The rising burden of diabetic kidney disease (DKD) and its associated lipid abnormalities underscores the need for new mechanistic insights. Uromodulin, a kidney-enriched protein, has been associated with metabolic disorders in human studies, yet its functional role in systemic lipid metabolism remains elusive. In this study, transcriptomic datasets were analyzed to investigate uromodulin expression and biological function in DKD. Subsequently, a diabetic model was induced in UMOD+/+ and UMOD−/− rats using a combination of a high-fat diet, unilateral nephrectomy, and streptozotocin to assess renal and metabolic phenotypes. Public RNA-seq data indicated that uromodulin expression was downregulated in DKD and was enriched in the fatty acid metabolism pathway. At baseline, UMOD−/− rats resembled UMOD+/+ rats in terms of growth, routine serum lipids, and major organ function. However, in diabetes, UMOD−/− rats exhibited higher mortality and pronounced hyperlipidemia. Hyperlipidemia occurred prior to the onset of renal dysfunction. Of note, this exacerbated lipid dysregulation represented a lipodystrophy-like phenotype rather than secondary changes in the pancreas, liver, or circulating cytokines (IL-6, IL-1β, and TNF-α). Moreover, UMOD−/− rats displayed exacerbated tubular injury and enhanced renal lipid accumulation in DKD relative to UMOD+/+ rats. Collectively, uromodulin protects diabetic rats from death, prevents epididymal white adipose tissue from browning, and attenuates kidney injury. Our findings identify uromodulin as a novel regulator of the kidney–adipose axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing 100034, China.
- Institute of Nephrology, Peking University, Beijing 100034, China.
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing 100034, China.
- Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing 100034, China.
ORCID-Profile: Yuqing Chen
Förderung
- National Natural Science Foundation of China
- National High-Level Hospital Clinical Research Funding
Zitieren
APA
Cheng, L., Xing, Z., Song, D., Hu, N., Wang, C., & Chen, Y. (2026). Uromodulin: A Novel Regulator of the Kidney–Adipose Axis in Diabetic Kidney Disease. International Journal of Molecular Sciences, 27(13), 6009. https://doi.org/10.3390/ijms27136009
Vancouver
Cheng L, Xing Z, Song D, Hu N, Wang C, Chen Y. Uromodulin: A Novel Regulator of the Kidney–Adipose Axis in Diabetic Kidney Disease. International Journal of Molecular Sciences. 2026;27(13):6009. doi:10.3390/ijms27136009
BibTeX
@article{Cheng2026,
author = {Cheng, Linan and Xing, Zheyu and Song, Di and Hu, Nan and Wang, Chunyue and Chen, Yuqing},
title = {Uromodulin: A Novel Regulator of the Kidney–Adipose Axis in Diabetic Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {6009},
doi = {10.3390/ijms27136009}
}
EUVIMED